Home » Topics » BioWorld

BioWorld
RSS

CENTOCOR ACQUIRES DIAGNOSTICS COMPANY

Feb. 5, 1992

UNIVAX IPO RAKES IN $48 MILLION

Feb. 5, 1992

ADVANCED POLYMER NETS $8.74 MILLION

Feb. 5, 1992

ANALYSTS RAISE AMGEN ESTIMATES

Feb. 5, 1992

ATRIX TO DELAY PERIODONTAL DRUG NDA

Feb. 5, 1992

LA JOLLA PHARM. RAISES $14 MILLION

Feb. 5, 1992

U.S. BIO PLANS FEBRUARY MEETING WITH FDA

Feb. 5, 1992

ANALYSTS QUESTION U.S. BIO STOCK TRADING

Feb. 5, 1992

U.S. BIO PLUNGES AFTER FDA REBUFF

Feb. 4, 1992

AMERICAN BIOGENETIC TO REDEEM WARRANTS

Feb. 4, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.